 WESTLAKE VILLAGE, Calif. and DANBURY, Conn., Sept. 29, 2021 GLOBE NEWSWIRE -- MannKind Corporation Nasdaq: MNKD, a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that it has entered into a sale-leaseback transaction with an affiliate of Creative Manufacturing Properties, which will generate 102.25 million in gross proceeds upon closing. 